enow.com Web Search

  1. Ads

    related to: approved uses for singulair
  2. goodrx.com has been visited by 100K+ users in the past month

    109 S High St #100, Columbus, OH · Directions · (614) 224-4261

Search results

  1. Results from the WOW.Com Content Network
  2. Montelukast - Wikipedia

    en.wikipedia.org/wiki/Montelukast

    Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma. [6] It is generally less preferred for this use than inhaled corticosteroids. [6] It is not useful for acute asthma attacks. [6] Other uses include allergic rhinitis and hives of long duration. [6]

  3. Cysteinyl-leukotriene type 1 receptor antagonists - Wikipedia

    en.wikipedia.org/wiki/Cysteinyl-leukotriene_type...

    The medical uses for Cysteinyl-leukotriene type 1 receptor antagonists are for chronic and prophylactic treatment of asthma. [3] [9] [10] Other indications have been approved by the FDA for montelukast and they are used for the prevention of exercise-induced bronchoconstriction (EIB), relief of symptoms of allergic rhinitis (AR) that is for relief of seasonal allergic rhinitis and perennial ...

  4. Exclusive-US FDA finds widely used asthma drug impacts ... - AOL

    www.aol.com/news/exclusive-us-fda-finds-widely...

    By 2019, the FDA tallied 82 suicides linked to Singulair and its generic versions reported to its adverse-event database since 1998. At least 31 of those reports involved someone age 19 or younger.

  5. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  6. Merck's Crash of a Titan - AOL

    www.aol.com/news/2013-02-12-mercks-crash-of-a...

    Merck's blockbuster asthma and allergy treatment Singulair fell off patent last year -- wiping more than 60% of revenue off the company's top line. With another expiration around the bend, the ...

  7. Merck's Dynamic Duo - AOL

    www.aol.com/news/2013-02-14-mercks-dynamic-duo.html

    Merck lost blockbuster asthma drug Singulair off the patent cliff last year, and the sales plunge quickly followed. With a mixed bag of pipeline projects, the company has to depend upon the ...

  8. Zafirlukast - Wikipedia

    en.wikipedia.org/wiki/Zafirlukast

    Zafirlukast is FDA-approved for the prevention and treatment of asthma in adults and children older than 5 years old. [1] Like other leukotriene receptor antagonists, zafirlukast is thought to be useful for the long-term treatment of asthma, but it is generally less effective than inhaled glucocorticoids as monotherapy (which are the standard of care) or long-acting beta-2 agonists in ...

  9. Does This Pipeline Promise Tomorrow's Blockbuster Sales? - AOL

    www.aol.com/news/2013-06-12-does-this-pipeline...

    Nearly every big pharma player has been hit with patent expirations that have hit hard on sales lately, and Merck is no exception. Merck's one of the industry's biggest giants, but the loss of ...

  1. Ads

    related to: approved uses for singulair